Acquandas manufactures thin-film nitinol actuators capable of pulling **550 times their own weight** with a film thickness of **50 micrometers**. The company applies its thin-film technology beyond brain implants, demonstrating versatility in high-performance actuator applications. These devices leverage nitinol’s shape-memory properties for precision mechanical control in medical and industrial systems.
Feb 2024Medical Design and OutsourcingNews article
Synchron, a brain-computer interface (BCI) technology company, acquires an equity stake in Acquandas, a manufacturer of high-precision components. The deal aims to bolster Synchron’s supply chain for advanced medical devices. No financial details of the acquisition have been disclosed.
Synchron acquires a stake in Acquandas, a German company producing high-precision thin-film components for healthcare and other sectors. The move expands Synchron’s capabilities in advanced manufacturing for brain-computer interface (BCI) devices. Acquandas’s expertise in precision thin films supports Synchron’s development of implantable neural technologies.
Synchron acquires a stake in a manufacturer to scale production of its brain-computer interface device ahead of commercial launch. The move supports the neurotech startup’s efforts to meet anticipated market demand for its flagship product. Synchron competes directly with Neuralink in developing implantable neural technologies.
